{"id":64000,"title":"A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.","abstract":"","date":"2014-02-28","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24381226","annotations":[{"name":"Chronic (medicine)","weight":0.684638,"wikipedia_article":"http://en.wikipedia.org/wiki/Chronic_(medicine)"},{"name":"Leukemia","weight":0.625231,"wikipedia_article":"http://en.wikipedia.org/wiki/Leukemia"},{"name":"Protein","weight":0.560061,"wikipedia_article":"http://en.wikipedia.org/wiki/Protein"},{"name":"Therapy","weight":0.492836,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Lymphocyte","weight":0.235482,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphocyte"},{"name":"B-cell chronic lymphocytic leukemia","weight":0.0503012,"wikipedia_article":"http://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia"},{"name":"Protein-protein interaction","weight":0.046733,"wikipedia_article":"http://en.wikipedia.org/wiki/Protein-protein_interaction"},{"name":"Monospecificity","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Monospecificity"},{"name":"Lymphoid leukemia","weight":0.0224886,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphoid_leukemia"},{"name":"Phase (waves)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Phase_(waves)"},{"name":"Safety","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Safety"},{"name":"Tolerability","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Tolerability"}]}
